Kyntra Bio (KYNB) Net Shares Issued and Repurchased (2015 - 2025)

Kyntra Bio has disclosed Net Shares Issued and Repurchased across 11 years of filings, most recently posting $263000.0 for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased fell 95.5% year-over-year to $263000.0; the TTM figure through Dec 2025 stood at $263000.0 (down 95.5% YoY), while the FY2025 annual figure was $263000.0, down 95.5% from the prior year.
• Net Shares Issued and Repurchased came in at $263000.0 for Q4 2025 at Kyntra Bio, down from $5.8 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $5.8 million in Q4 2024 to a low of $263000.0 in Q4 2025.
• Average Net Shares Issued and Repurchased over 5 years is $3.6 million, with a median of $3.5 million recorded in 2021.
• Year-over-year, Net Shares Issued and Repurchased soared 97.73% in 2023 and sank 95.5% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $3.5 million in 2021, then decreased by 15.93% to $2.9 million in 2022, then jumped by 97.73% to $5.7 million in 2023, then rose by 1.92% to $5.8 million in 2024, then slumped by 95.5% to $263000.0 in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $263000.0 in Q4 2025, $5.8 million in Q4 2024, and $5.7 million in Q4 2023.